SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS by De Wit, J, Al-Mossawi, M, Huhn, M, Arancibia, C, Powrie, F, Bowness, P

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis by Leucht, S, Chaimani, A, Mavridis, D, Leucht, C, Huhn, M, Helfer, B, Samara, M, Cipriani, A, Geddes, J, Davis, J

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response by Leucht, S, Chaimani, A, Leucht, C, Huhn, M, Mavridis, D, Helfer, B, Samara, M, Cipriani, A, Geddes, JR, Salanti, G, Davis, JM

A Human Recombinant Autoantibody-Based Immunotoxin Specific for the Fetal Acetylcholine Receptor Inhibits Rhabdomyosarcoma Growth In Vitro and in a Murine Transplantation Model by Gattenloehner, S, Joerissen, H, Huhn, M, Vincent, A, Beeson, D, Tzartos, S, Mamalaki, A, Etschmann, B, Muller-Hermelink, H, Koscielniak, E, Barth, S, Marx, A

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors. by Leucht, S, Leucht, C, Huhn, M, Chaimani, A, Mavridis, D, Helfer, B, Samara, M, Rabaioli, M, Bächer, S, Cipriani, A, Geddes, J, Salanti, G, Davis, J

Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development by Pillinger, T, Howes, OD, Correll, CU, Leucht, S, Huhn, M, Schneider-Thoma, J, Gaughran, F, Jauhar, S, McGuire, PK, Taylor, DM, Young, AH, McCutcheon, RA

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors by Leucht, S, Leucht, C, Huhn, M, Chaimani, A, Mavridis, D, Helfer, B, Samara, M, Rabaioli, M, Bächer, S, Cipriani, A, Geddes, J, Salanti, G, Davis, J

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis by Huhn, M, Nikolakopoulou, A, Schneider-Thoma, J, Krause, M, Samara, M, Peter, N, Arndt, T, Bäckers, L, Rothe, P, Cipriani, A, Davis, J, Salanti, G, Leucht, S

CD161int CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut by Klenerman, P, Fergusson, J, Willberg, C, Powrie, F, Hühn, M, Kurioka, A, Barnes, E, L., S, L.J., W, Llibre, A, Bertoletti, A, Holländer, G, Newell, E, Davis, M, Sverremark-Ekström, E, Capone, S, Folgori, A, Ussher, J

RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease. by de Wit, J, Al-Mossawi, M, Hühn, M, Arancibia-Cárcamo, C, Doig, K, Kendrick, B, Gundle, R, Taylor, P, Mcclanahan, T, Murphy, E, Zhang, H, Barr, K, Miller, J, Hu, X, Aicher, T, Morgan, R, Glick, G, Zaller, D, Correll, C, Powrie, F, Bowness, P

Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. by Cosgrove, C, Ussher, J, Rauch, A, Gärtner, K, Kurioka, A, Hühn, M, Adelmann, K, Kang, Y, Fergusson, JR, Simmonds, P, Goulder, P, Hansen, T, Fox, J, Günthard, H, Khanna, N, Powrie, F, Steel, A, Gazzard, B, Phillips, R, Frater, J, Uhlig, H, Klenerman, P

Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells by Chen, H, Handel, N, Ngeow, J, Muller, J, Huhn, M, Yang, H, Heindl, M, Berbers, R, Hegazy, A, Kionke, J, Yehia, L, Sack, U, Blaser, F, Rensing-Ehl, A, Reifenberger, J, Keith, J, Travis, S, Merkenschlager, A, Keiss, W, Wittekind, C, Walker, L, Ehl, S, Aretz, S, Dustin, M, Eng, C, Powrie, F, Uhlig, H